Structure Therapeutics Inc. Sponsored ADR (GPCR)
(Delayed Data from NSDQ)
$36.62 USD
-1.70 (-4.44%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $36.60 -0.02 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum D VGM
Structure Therapeutics Inc. Sponsored ADR (GPCR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$87.40 | $118.00 | $65.00 | 128.08% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Structure Therapeutics Inc. Sponsored ADR comes to $87.40. The forecasts range from a low of $65.00 to a high of $118.00. The average price target represents an increase of 128.08% from the last closing price of $38.32.
Analyst Price Targets (10)
Broker Rating
Structure Therapeutics Inc. Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on nine recommendations.
Of the 10 recommendations deriving the current ABR, 10 are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 9 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/11/2024 | LifeSci Capital | Myriam Belghiti | Strong Buy | Strong Buy |
8/15/2024 | Cantor Fitzgerald & Co | Prakhar Agrawal | Strong Buy | Strong Buy |
8/12/2024 | Guggenheim Securities | Seamus Fernandez | Strong Buy | Strong Buy |
8/9/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
8/9/2024 | JMP Securities | Jonathan Wolleben | Strong Buy | Strong Buy |
6/7/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
6/3/2024 | SVB Securities | David Risinger | Strong Buy | Strong Buy |
5/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 10 |
Average Target Price | $87.40 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | -0.19 |
GPCR FAQs
Structure Therapeutics Inc. Sponsored ADR (GPCR) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for Structure Therapeutics Inc. Sponsored ADR (GPCR) is $87.40. The current on short-term price targets is based on 6 reports.
The forecasts for Structure Therapeutics Inc. Sponsored ADR (GPCR) range from a low of $65 to a high of $118. The average price target represents a increase of $138.67 from the last closing price of $36.62.
The current UPSIDE for Structure Therapeutics Inc. Sponsored ADR (GPCR) is 138.67%
Based on short-term price targets offered by 10 analysts, the average price target for Structure Therapeutics Inc. Sponsored ADR comes to $87.40. The forecasts range from a low of $65.00 to a high of $118.00. The average price target represents an increase of 128.08% from the last closing price of $38.32.